Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex

EMBO Journal

Volumn 18, Issue 3, 1999, Pages 644-653

  Ellis, Mark ^a   Chew, Yat Peng ^a   Fallis, Lynn ^b   Freddersdorf, Steffen ^b,c   Boshoff, Chris ^a   Weiss, Robin A ^a   Lu, Xin ^b   Mittnacht, Sibylle ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cyclin; HHV8; KSHV; p27(Kip); Phosphorylation; Protein degradation

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; PROTEIN P27; THREONINE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TISSUE CULTURE CELL; TRANSACTIVATION;

BASE SEQUENCE; BINDING SITES; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA PRIMERS; ENZYME INHIBITORS; HERPESVIRUS 8, HUMAN; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SARCOMA, KAPOSI; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8;

EID: 0033081619     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.3.644     Document Type: Article

References (51)

1. Aktas, H., Cai, H. and Cooper, G.M. (1997) Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol., 17, 3850-3857.
2. Boshoff, C. et al. (1998) Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood, 91, 1671-1679.
3. Boyle, W.J., van der Geer, P. and Hunter, T. (1991) Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol., 201, 110-149.
4. Carnero, A. and Hannon, G.J. (1998) The INK4 family of CDK inhibitors. Curr. Topics Microbiol. Immunol., 227, 43-55.
5. Cesarman, E., Chang, Y., Moore, P.S., Said, J.W. and Knowles, D.M. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med., 332, 1186-1191.
6. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M. and Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865-1869.
7. Chellappan, S.P., Giordano, A. and Fisher, P.B. (1998) Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr. Top. Microbiol. Immunol., 227, 57-103.
8. Esposito, V. et al. (1997) Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res., 57, 3381-3385.
9. Gaidano, G., Cechova, K., Chang, Y., Moore, P.S., Knowles, D.M. and Dalla, F.R. (1996) Establishment of AIDS-relatcd lymphoma cell lines from lymphomatous effusions. Leukemia, 10, 1237-1240.
10. Godden Kent, D., Talbot, S.J., Boshoff, C., Chang, Y., Moore, P., Weiss, R.A. and Mittnacht, S. (1997) The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastomaprotein and histone H1. J. Virol., 71, 4193-4198.
11. Harlow, E. and Lane, D. (1998) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
12. Herwig, S. and Strauss, M. (1997) The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur. J. Biochem., 246, 581-601.
13. Hsieh, J.K., Fredersdorf, S., Kouzarides, T., Martin, K. and Lu, X. (1997) E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev., 11, 1840-1852.
14. Hunter, T. and Pines, J. (1991) Cyclins and cancer. Cell, 66, 1071-1074.
15. Kawada, M., Yamagoe, S., Murakami, Y., Suzuki, K., Mizuno, S. and Uehara, Y. (1997) Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene, 15, 629-637.
16. Li, M., Lee, H., Yoon, D.W., Albrecht, J.C., Fleckenstein, B., Neipel, F. and Jung, J.U. (1997) Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol., 71, 1984-1991.
17. Lloyd, A.C. (1998) Ras versus cyclin-dependent kinase inhibitors. Curr. Opin. Genet. Dev., 8, 43-18.
18. Loda, M., Cukor, B., Tam, S.W., Lavin, P., Fiorentino, M., Draetta, G.F., Jessup, J.M. and Pagano, M. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med., 3, 231-234.
19. Lundberg, A.S. and Weinberg, R.A. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol., 18, 753-761.
20. Mal, A., Poon, R.Y., Howe, P.H., Toyoshima, H., Hunter, T. and Harter, M.L. (1996) Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature, 380, 262-265.
21. Meijer, L., Borgne, A., Mulner, O., Chong, J.P., Blow, J.J., Inagaki, N., Inagaki, M., Delcros, J.G. and Moulinoux, J.P. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem., 243, 527-536.
22. Meijer, L. and Kim, S.H. (1997) Chemical inhibitors of cyclin-dependent kinases. Methods Enzymol., 283, 113-128.
23. Miller, C.W. and Koeffler, H.P. (1997) Cyclin-dependent kinase inhibitors in human neoplasms. Leukemia, 3, 370-371.
24. Mittnacht, S. (1998) Control of pRB phosphorylation. Curr. Opin. Genet. Dev., 8, 21-27.
25. Moore, P.S. and Chang, Y. (1998) Antiviral activity of tumour suppressor pathways: clues from molecular piracy by KSHV. Trends Genet., 14, 144-150.
26. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
27. Morgan, D.O. (1997) Cyclin-dependent kinases: engines, clocks and microprocessors. Annu. Rev. Cell Dev. Biol., 13, 261-291.
28. Kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood, 86, 1924-1930.
29. Muller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W. and Eilers, M. (1997) Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene, 15, 2561-2576.
30. Nador, R.G., Cesarman, E., Chadburn, A., Dawson, D.B., Ansari, M.Q., Said, J. and Knowles, D.M. (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood, 88, 645-656.
31. Palmero, I. and Peters, G. (1996) Perturbation of cell cycle regulators in human cancer. Cancer Surv., 27, 351-367.
32. Perez, R.I., Solomon, D.L., Sewing, A. and Land, H. (1997) Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27 (Kip1) binding to newly formed complexes. Oncogene, 14, 2373-2381.
33. Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massagué, J., Roberts, J.M. and Koff, A. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
34. Porter, P.L., Malone, K.E., Heagerty, P.J., Alexander, G.M., Gatti, L.A., Firpo, E.J., Daling, J.R. and Roberts, J.M. (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med., 3, 222-225.
35. Reynisdottir, I., Polyak, K., Iavarone, A. and Massagué, J. (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9, 1831-1845.
36. Sarid, R., Flore, O., Bohenzky, R.A., Chang, Y. and Moore, P.S. (1998) Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol., 72, 1005-1012.
37. Sheaff, R.J., Groudine, M., Gordon, M., Roberts, J.M. and Clurman, B.E. (1997) Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev., 11, 1464-1478.
38. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
39. Shi, Y., Zou, M., Farid, N.R. and Al, S.S. (1996) Evidence of gene deletion of p21 (WAF1/C1P1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas. Br. J. Cancer, 74, 1336-1341.
40. Spirin, K.S., Simpson, J.F., Takeuchi, S., Kawamata, N., Miller, C.W. and Koeffler, H.P. (1996) p27/Kip1 mutation found in breast cancer. Cancer Res., 56, 2400-2404.
41. 1 cyclin-cdk complexes. EMBO J., 14, 4814-4826.
42. Swanton, C. Mann, D.J., Fleckenstein, B., Neipel, F., Peters, G. and Jones, N. (1997) Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature, 390, 184-187.
43. 1 phase required for p27kip1 downregulation, passage through the restriction point and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol., 17, 5348-5358.
44. Tan, P., Cady, B., Wanner, M., Worland, P., Cukor, B., Magi, G.C., Lavin, P., Draetta, G., Pagano, M. and Loda, M. (1997) The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res., 57, 1259-1263.
45. Van den Heuvel, S. and Harlow, E. (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science, 262, 2050-2054.
46. Vlach, J., Hennecke, S. and Amati, B. (1997) Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J., 16, 5334-5344.
47. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
48. Yang, R.M., Naitoh, J., Murphy, M., Wang, H.J., Phillipson, J., deKernion, J.B., Loda, M. and Reiter, R.E. (1998) Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol., 159, 941-945.
49. 1/S cyclin-dependent kinases. J. Biol. Chem., 272, 12738-12746.
50. Zerfass, T.K., Zwerschke, W., Mannhardt, B., Tindle, R., Botz, J.W. and Jansen, D.P. (1996) Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene, 13, 2323-2330.
51. Zhong, W., Wang, H., Herndier, B. and Ganem, D. (1996) Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl Acad. Sci. USA, 93, 6641-6646.